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 Abstract 
  Background:   Hemoglobin tetramers are the major oxygen-carrying molecules within the 
blood. We hypothesized that a lower hemoglobin level and its reduced oxygen-carrying capac-
ity would associate with larger infarction in acute ischemic stroke patients.   Methods:   We stud-
ied 135 consecutive patients with acute ischemic stroke and perfusion brain MRI. We explored 
the association of admission hemoglobin with initial infarct volumes on acute images and the 
volume of infarct expansion on follow-up images. Multivariable linear regression was per-
formed to analyze the independent effect of hemoglobin on imaging outcomes.   Results:   Bi-
variate analyses showed a significant inverse correlation between hemoglobin and initial vol-
ume in diffusion-weighted imaging (r = –0.20, p = 0.02) and absolute infarct growth (r = –0.20, 
p = 0.02). Multivariable linear regression modeling revealed that hemoglobin remained inde-
pendently predictive of larger infarct volumes acutely (p   !   0.005) and with greater infarct ex-
pansion (p   !   0.01) after adjusting for known covariates.   Conclusions:   Hemoglobin level at the 
time of acute ischemic stroke associates with larger infarcts and increased infarct growth. Clar-
ification of the mechanism of this effect may yield novel insights for therapy. 
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 Introduction 
  Ischemic stroke is the third leading cause of death in the US, and the leading cause of 
disability. Reperfusion represents the mainstay of therapy, however only a small fraction of 
patients qualify for these treatments. A better understanding of the elements that contribute 
to the growth of stroke in humans may provide insights into novel treatments. Studies that 
have explored the influences on stroke outcomes have identified a small number of modifi-
able risk factors (i.e. blood glucose   [1, 2]   and blood pressure   [3]  ), but interventions unfortu-
nately have not improved neurological outcomes   [3, 4]  . Thus, there is an urgent need to bet-
ter understand and identify additional contributors to infarct growth, and to determine 
whether they can be targeted therapeutically.
  Since cerebral infarction results from an imbalance between energy supply and demand, 
exploring factors that alter this balance may yield such insights. The fact that reperfusion 
approaches have shown consistent, albeit variable benefit emphasizes the proximate role that 
energy supply plays in affecting stroke outcomes. With this in mind, we hypothesized that 
the oxygen-carrying capacity of the blood may influence the outcome of ischemic brain tis-
sue. Utilizing a cohort of acute stroke patients with perfusion brain MRI scans, we sought to 
determine whether reduced levels of hemoglobin were associated with larger infarcts. We 
also evaluated whether these parameters were associated with infarct expansion.
  M e t h o d s  
 Study  Population 
  The study population consisted of consecutive patients with acute ischemic stroke pre-
senting to the emergency department of a single academic center who had diffusion-weight-
ed images (DWI) and perfusion-weighted MRI within 12 h of symptom onset and a follow-
up image after 5–100 days (median 12 days, interquartile range 6–55 days). The study was a 
retrospective analysis of patients recruited as part of a prospective study (MRI Diffusion/ 
Perfusion Mismatch in Human Acute Stroke) from 1996 to 2009. Part of the study popula-
tion has been investigated in previous publications   [5, 6]  . Patients who had received any 
thrombolytic or investigational treatments or patients in whom the final infarct volume 
could not be assessed due to motion artifact, hemorrhagic conversion, massive cerebral ede-
ma or hemicraniectomy were excluded.
    Variables that could potentially influence acute infarct volume were recorded in each 
patient. These included age, gender, the causative classification system (CCS) etiologic stroke 
subtypes   [7]  , admission NIH stroke scale (NIHSS) score, admission blood glucose and time 
to MRI. Although there were few subjects with small-vessel stroke, exclusion of these subjects 
did not alter the results. Hemoglobin values were retrospectively obtained from the medical 
records, with the first value on presentation being recorded. For follow-up imaging analysis, 
we included the time to follow-up and the volume of perfusion-diffusion mismatch along 
with the other previously stated variables. The study was conducted at a single academic cen-
ter and the study protocol was approved by the local institutional review board.
  Image  Acquisition 
  MRI was performed on 1.5- or 3-tesla whole-body scanners (GE Signa; GE Medical Sys-
tems, or Siemens Sonata; Siemens Medical Solutions). DWI were obtained using echo planar 
imaging with b values (diffusion weighting) of 0 and 1,000 s/mm  2  . DWI data sets were cor-
rected for motion and eddy current distortion  [8] . Trace DWI maps were calculated from the 
geometric mean of the high b value images. Perfusion-weighted images were acquired using 46
Cerebrovasc Dis Extra 2011;1:44–53
 DOI:  10.1159/000328219 
  Kimberly et al.: Lower Hemoglobin Correlates with Larger Strokes 
www.karger.com/cee
    © 2011 S. Karger AG, Basel
  Published online: May 17, 2011 
EXTRA
dynamic susceptibility contrast gradient echo or spin echo planar imaging. Images were ac-
quired during the first pass of a bolus of 0.1 (gradient echo) or 0.2 mmol/kg of body weight 
(spin echo) of the contrast agent gadopentetate dimeglumine (Magnevist; Berlex Laborato-
ries) injected with an MRI-compatible power injector (MEDRAD). Mean transit time (MTT) 
maps were calculated using methods described previously   [9]   where the arterial input func-
tion was selected manually or automatically with manual review. Follow-up imaging studies 
consisted of either fast spin echo T  2  -weighted, fluid-attenuated inverted recovery (n = 104) 
or non-contrast CT images (n = 31).
  Image  Analysis 
  The lesion on DWI, the final T2-weighted, fluid-attenuated inverted recovery or non-
contrast CT images, and MTT maps were visually identified and outlined using image dis-
play and analysis programs (ALICE, Hayden Image Processing Solutions; MRIcro, Univer-
sity of Arizona, and Display, McConnell Brain Imaging Center, Montreal Neurological In-
stitute). All lesion volumes were manually outlined and (for the MTT maps) compared to the 
contralateral hemisphere to confirm the region of abnormality. Lesion outlines were inde-
pendently reviewed for accuracy by a trained neuroradiologist, and volumes were calculated 
from the outlines. We previously found that the interexaminer reliability of this technique 
was high (intraclass correlation coefficient = 0.99)   [5]  .
  S t a t i s t i c s  
  Bivariate analyses were used to assess the relationship between initial DWI volume and 
the following clinical covariates: CCS Trial of Org 10172 in Acute Stroke Treatment (TOAST) 
etiologic stroke subtype   [7]  , age, gender, hemoglobin, time to acute DWI, time to follow-up 
image, NIHSS score and admission blood glucose. Age and gender were specifically includ-
ed in the analysis because of their potential confounding association with hemoglobin levels. 
Other variables were chosen because of their previously reported association with these im-
aging outcomes. Bivariate relationships were tested using Pearson’s correlation, or Wilcox-
on’s rank sum and Kruskal-Wallis tests, as appropriate. We also explored whether hemoglo-
bin demonstrated a U-shaped relationship with imaging outcomes by performing a bivariate 
quadratic regression analysis. 
    Standard least-square linear regression models were developed to test for independence 
of hemoglobin as a predictor of initial DWI volume and volume of infarct growth. All other 
clinical variables with an a priori hypothesized effect on hemoglobin or the imaging out-
come, or with bivariate p   ^   0.2 were entered into the multivariate models. Because DWI le-
sion volume did not conform to a normal distribution, the data were log transformed before 
analysis   [10]  . In the analysis of infarct growth (final stroke volume – acute stroke volume), 
the time to follow-up scan and the size of the perfusion-diffusion mismatch deficit (MTT-
DWI) were included since these variables may influence infarct size and growth. After the 
final models were developed, the interaction between hemoglobin and age, and hemoglobin 
and gender were specifically examined by introducing these dual interaction terms. All nu-
meric variables were expressed as means   8   SD or medians (interquartile ranges, IQR). A 
level of p   !   0.05 was considered statistically significant.
  R e s u l t s  
  A total of 3,471 consecutive patients with ischemic stroke were admitted during the 
study period. Of them, 594 patients met the inclusion criteria and 335 of the 594 were eligible 
but excluded. Reasons for exclusion were refused consent (88), death and/or comfort measure 47
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only (CMO) (47), no acute lesion on MRI (44), inability to attend follow-up (27), new claus-
trophobia or anxiety (26), MRI technique failure (26), loss to follow-up (19), hemicraniec-
tomy (18), lack of a follow-up image due to protocol restrictions (17), inability to obtain con-
sent (11), severe cerebral edema (6), subacute lesion on MRI (3), and acute hemorrhagic in-
farction (3). Thus, the total study population consisted of 259 patients. Of these, 153 patients 
were prospectively collected, and 106 patients were retrospectively collected applying identi-
cal criteria. 
    Within the resulting patient population, the study group was defined a priori as the 
natural history cohort: therefore, 72 were excluded due to intravenous tissue plasminogen 
activator administration, 38 due to investigational drug studies [hyperoxia (22), induced hy-
pertension (10), and desmoteplase (6)], 6 due to intra-arterial tissue plasminogen activator, 4 
due to emergency carotid bypass surgery, 3 due to intra-arterial mechanical thrombolysis, 
and 1 due to an investigational interventional NeuroFlo device. Further analyses included 
the subsequent 135 patients.   Table 1   summarizes the baseline characteristics, and clinical 
and imaging features of this cohort. Cerebral infarcts were located within the middle cere-
bral artery territory in 96 patients, anterior cerebral artery territory in 4 patients, posterior 
cerebral artery territory in 11 patients, internal carotid artery territory in 5 patients, and 
basilar artery and/or cerebellar artery territories in 19 patients. Ischemic lesion volumes on 
acute and follow-up images and volume of growth are also listed in   table 1  .
    Hemoglobin level demonstrated a statistically significant inverse correlation with acute 
DWI volume (r = –0.20, p = 0.02) and volume of infarct growth (r = –0.20, p = 0.02). Admis-
sion blood glucose was associated with infarct growth (r = 0.18, p = 0.04), but not with initial 
acute DWI volume (p   1   0.20), which is consistent with prior reports   [1, 2, 5]  .  CCS-TOAST 
stroke subtypes  demonstrated a statistically significant association with initial infarct vol-
ume   [11]   (p = 0.04), but not with infarct expansion (p = 0.11). NIHSS scores were available 
for a subset of patients (n = 85), and analysis of these patients showed correlation with acute 
Table 1. B  aseline characteristics and clinical/imaging features
Age, years (mean 8 SD) 65815
Female patients, n 45 (33%)
Hemoglobin, g/dl (mean 8 SD)
Female
Male
12.981.6
14.581.6
Median admission blood glucose, mg/dl (IQR) 117 (104–139) 
Median admission NIHSS (IQR) 4 (2–9)
CCS-TOAST stroke subtype, n of patients
Large artery atherosclerosis 37
Cardioaortic embolism 58
Small artery occlusion 3
Other causes 16
Undetermined causes 21
Time to acute MRI, h (mean 8 SD) 683
Time to admission hemoglobin, h (mean 8 SD) 583
Median DWI lesion volume, ml (IQR) 7.3 (1.5–30.0)
Median acute MTT lesion volume, ml (IQR) 55.9 (6.5–146.6)
Median follow-up infarct volume, ml (IQR) 11.9 (2.4–51.1)
Median time to follow-up scan, days (IQR) 12 (6–55)
Median volume of infarct growth, ml (IQR) 2.3 (–0.6 to 18.2)
I  QR = Interquartile range. Other causes include cervical artery dissection, hypercoagulability syn-
drome, iatrogenic causes and cocaine.48
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DWI volume (r = 0.50, p   !   0.001) and infarct growth (r = 0.35, p   !   0.001). Time to follow-up 
scan was also correlated with the volume of infarct growth (r = –0.27, p   !   0.01). Other com-
parisons, including age, gender, and time-to-acute MRI, did not demonstrate significant cor-
relations with the above imaging outcomes.
  We also evaluated the correlation between hemoglobin and the imaging outcomes, strat-
ified by sex, since women have lower hemoglobin levels than men. We found the inverse cor-
relation was consistent for men (n = 90; r = –0.27, p = 0.01 for acute DWI volume, and r = 
–0.22, p = 0.04 for infarct growth) and also present for women (n = 45; r = –0.26, p = 0.08 for 
acute DWI volume, and r = –0.42, p = 0.004 for infarct growth). Because hemoglobin may 
be a marker for chronic disease, we evaluated whether there was an association between he-
moglobin level and Framingham stroke risk score  [12] . In patients in whom a risk score could 
be calculated (n = 94), there was no significant correlation with hemoglobin (r = –0.03, p = 
0.77). We also evaluated the association between hemoglobin level and individual stroke risk 
factors including type II diabetes (p = 0.46), coronary heart disease (p = 0.25), atrial fibrilla-
tion (p = 0.32), hypertension (p = 0.03), hyperlipidemia (p = 0.56), smoking (p = 0.67) and 
CCS (p = 0.08). Hypertensive subjects had higher hemoglobin levels (14.3 vs. 13.7 g/dl), but 
hypertension was not statistically significantly associated with either acute DWI volume or 
infarct growth. Together, these data argue that hemoglobin is not a marker for chronic dis-
ease based on other known risk factors for stroke.
    We next constructed a multivariable regression model, which demonstrated that hemo-
globin was an independent predictor for acute DWI volume (p   !   0.005).   Table 2   lists the co-
variables included in the model, including age, gender, admission glucose, time to acute MRI 
and CCS stroke subtype. Because the effect of hemoglobin may be influenced by either age 
or sex, we explored the interaction of gender   hemoglobin  and  age   hemoglobin post hoc in 
the model. However, neither interaction term had a statistically significant effect on the 
model (both p   1   0.20). We also included admission NIHSS score into the model post hoc 
because this value was not available for all patients (n = 85). In this model with fewer total 
subjects, hemoglobin remained an independent predictor of acute DWI volume (p = 0.03, 
 table 2 ). 
Table 2. M  ultivariate relationships with acute infarct volume as the dependent variable
Acute infarct volume Without NIHSS (n = 135) With NIHSS (n = 85)
coefficient p coefficien t p
Age –0.003 0.53 –0.007 0.13
Female sex –0.22 <0.01 –0.23 <0.02
Admission glucose 0.003 0.02 0.002 0.16
Admission hemoglobin –0.14 <0.005 –0.11 0.03
Stroke subtype 0.04 0.03
Large artery 0.08 0.58 0.09 0.55
Cardioembolic 0.28 0.04 0.44 <0.01
Small artery –1.03 <0.01 –0.81 0.01
Other 0.26 0.17 0.10 0.65
Undetermined 0.41 0.02 0.19 0.34
Time to acute MRI 0.02 0.34 –0.004 0.86
NIHSS – – 0.07 <0.001
p v  alues of significant differences are italicized.49
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    We also explored the independent effect of hemoglobin on infarct growth (  table 3  ). We 
evaluated absolute infarct growth, rather than its percentage, which has been shown to be 
associated with neurological outcome   [13]  . We included the volume of the perfusion-diffu-
sion mismatch, the time to the follow-up scans, and all other variables used previously. He-
moglobin was independently associated with infarct growth (p = 0.02). Additional variables 
that exhibited independent effects were gender (p = 0.01), stroke subtype (p = 0.03) and
NIHSS score (p   !   0.01). Based on this model, for each drop in hemoglobin of 1 g/dl, there is 
a 5.5   8   2.4 cm  3   increase in the volume of infarct growth (  fig. 1  ).
    Because elevated hematocrit has been reported to associate with infarct expansion   [14]  , 
we explored whether a U-shaped polynomial association existed with hemoglobin levels. We 
found that in bivariate analysis, quadratic regression provided a statistically significantly 
Table 3. M  ultivariate relationships with volume of stroke growth as the dependent variable
Infarct growth Coefficient p
Age –0.10 0.64
Gender –9.92 0.01
Admission glucose 0.002 0.97
Admission hemoglobin –4.95 0.02
Stroke subtype 0.03
Large artery 0.46 0.94
Cardioembolic 1.53 0.80
Small artery –9.80 0.47
Other 25.88 <0.01
Undetermined –18.07 0.03
Time to follow up scan –0.12 0.23
NIHSS 1.59 <0.01
Perfusion-diffusion mismatch volume 0.05 0.21
p   values of significant differences are italicized.
Table 4. M  ultivariate relationships with volume of stroke growth as the dependent variable (only in those 
patients with perfusion-diffusion mismatch >120%)
Infarct growth in patients with mismatch Coefficient p
Age –0.07 0.76
Gender –11.26 0.02
Admission glucose 0.003 0.97
Admission hemoglobin –6.71 0.01
Stroke subtype 0.03
Large artery –0.17 0.99
Cardioembolic –2.68 0.76
Small artery –7.35 0.78
Other 31.77 0.01
Undetermined –21.57 0.06
Time to follow up scan –0.13 0.31
NIHSS 1.51 0.02
Perfusion-diffusion mismatch volume 0.05 0.32
p   values of significant differences are italicized.50
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improved fit compared to linear regression (p   !   0.01). However, when we analyzed this rela-
tionship in multivariable regression, incorporating hemoglobin with a quadratic term did 
not meet statistical criteria for a better fit than linear regression (p = 0.06), perhaps due to 
the few number of patients at the edges of the hemoglobin range.
    Finally, we performed a subset analysis only in patients who had oligemic brain tissue 
‘at risk’. Although perfusion MRI is imprecise in differentiating between benign oligemia 
and true penumbra, we reasoned that selecting all patients with a perfusion-diffusion mis-
match would provide a population of patients with greater risk for infarct growth; in 110 pa-
tients, perfusion volume was   6  120% of diffusion volume, a previously defined selection 
criterion   [10]  . Hemoglobin had a statistically significant inverse correlation with infarct 
growth (r = –0.20, p = 0.04), consistent with the entire cohort. In a multivariable analysis 
(  table 4  ), hemoglobin remained independently significant in this subgroup (p = 0.01), as did 
gender (p = 0.02), CCS stroke subtype (p = 0.03) and NIHSS (p = 0.02). Conversely, in patients 
who did not have a mismatch on perfusion MRI (n = 25), hemoglobin did not correlate with 
the volume of infarct expansion.
  Discussion 
  Using a systematic and carefully characterized cohort of acute ischemic stroke patients, 
we present data that lower hemoglobin values are associated with larger acute infarcts and 
an increased degree of infarct growth. This effect is independent of recognized variables that 
contribute to infarct size, including age, sex, admission blood glucose, NIHSS, CCS-TOAST 
stroke subtype and MRI perfusion parameters. 
  The mechanism by which lower hemoglobin associates with larger infarcts is unknown. 
However, one possible explanation may be through its influence on energy supply. Hemoglo-
bin carries 98% of the total blood oxygen, yet within one standard deviation of the normal 
range that level may vary by as much as 20%   [15]  . If a 20% reduced oxygen-carrying capac-
ity occurs in the context of normally functioning cerebrovasculature, autoregulatory mech-
anisms typically compensate by augmenting cerebral blood flow   [16]  . However, in the con-
text of ischemia, autoregulatory compensation is significantly impaired in the ischemic 
brain  [17] , with limited ability of the brain to increase the extraction of available oxygen  [18] . 
  Fig. 1.   Hemoglobin level versus 
infarct growth. 51
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The absolute oxygen-carrying capacity of the blood may therefore influence tissue fate under 
these circumstances and increase the conversion into infarct. 
    Available evidence in animal models of ischemic stroke suggests that lower hemoglobin 
reduces the threshold for ischemia   [19]   and results in larger infarct volumes   [20, 21]  . In hu-
man patients undergoing cardiopulmonary bypass, low hematocrit is associated with in-
creased risk of clinically detected perioperative stroke   [22]  . This is supported by mathemat-
ical modeling which demonstrates that lower hemoglobin may adversely affect the energy 
balance within the penumbra  [17] . Such modeling suggests a gradual and approximately lin-
ear change in oxygen metabolism at hemoglobin values  1 10 g/dl, with a more abrupt decline 
at levels below that. Our study population contained values primarily between 12 and 16
g/dl, and our data are consistent with a model whereby modest decreases in hemoglobin pre-
dict larger stroke volumes. 
    Prior animal   [16]   and some human data   [14]   have suggested that a high hematocrit (and 
therefore hemoglobin) level may also result in larger infarcts, perhaps through its influence 
on increasing blood viscosity. We investigated whether our data supported a deleterious ef-
fect of high hemoglobin by exploring a quadratic relationship between hemoglobin and in-
farct growth. While we found a U-shaped relationship in bivariate analysis, we were only able 
to demonstrate a trend for one in multivariable analysis. While this supports the notion that 
highly elevated and low hemoglobin are both associated with greater infarct expansion, fur-
ther analysis in a larger cohort of patients is needed for confirmation.
    There are several limitations to our analysis. First, our study was restricted only to pa-
tients with an initial brain MRI. Although rapid brain MRI scans are part of the standard of 
care in our stroke center, restricting our analysis to these patients could systematically bias 
against patients with delayed presentation and/or those patients with a contraindication to 
MRI. Moreoever, the median volume of strokes in our subjects was smaller than that in oth-
er populations of stroke patients   [23]   and this may restrict the generalizability of our results. 
It is possible that the higher acuity of patients with larger strokes made enrollment into our 
study a lower priority, where other clinical concerns may have superseded a rapid MRI. Fi-
nally, the time to the follow-up scan varied as a consequence of the retrospective nature of 
the study. However, when we adjusted for this variable, the association of hemoglobin with 
the imaging outcomes remained significant.
    Our study has several strengths. It involved a relatively large sample size of systemati-
cally collected data on stroke patients, and stroke volumes were assessed in a blinded fashion. 
Moreover, there was temporal proximity of the initial acute MRI to the admission hemoglo-
bin measurement. Finally, there was rigorous adjustment for potential confounders in our 
multivariable analyses.
    Hemoglobin is the key oxygen-carrying molecule in the body, and may therefore play a 
role in determining tissue fate within the penumbra. Our data demonstrate that lower he-
moglobin levels are associated with larger strokes and infarct growth. Future studies focused 
on investigating the association of hemoglobin with clinical outcome, and the mechanism of 
the association would ultimately guide potential treatment options.
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